山田 勢至

Medicine & Life Sciences

1. Glioma 100%
2. Isocitrate Dehydrogenase 83%
3. Neoplasms 63%
4. Astrocytoma 53%
5. Mutation 44%
6. Central Nervous System Neoplasms 41%
7. Ganglioglioma 37%
8. Glioblastoma 32%
9. Neurofibrillary Tangles 31%
10. Meningioma 27%
11. ATR-X syndrome 27%
12. Telomerase 26%
13. Magnetic Resonance Spectroscopy 26%
14. protoporphyrinogen 25%
15. DNA Methylation 25%
16. Central Nervous System 25%
17. Seizures 21%
18. Hypothalamic hamartomas 20%
19. Typical Teratoid Rhabdoid Tumor 20%
20. Atypical Teratoid Tumor 20%
21. Progressive Myoclonic Epilepsy 19%
22. Inositol 19%
23. Siderosis 19%
24. Survival 19%
25. Methylation 18%
26. Solitary Fibrous Tumors 18%
27. Hemangiopericytoma 17%
28. Mucormycosis 17%
29. Computer-Assisted Surgery 17%
30. Fluorescence 17%
31. polyglutamine 16%
32. Ependymoma 16%
33. Tumor-Infiltrating Lymphocytes 16%
34. Coronavirus 16%
35. Adenomatous Polyposis Coli 15%
36. Ewing's Sarcoma 15%
37. Cushing Syndrome 15%
38. Papillary Thyroid Cancer 14%
39. Choline 13%
40. Telomere Homeostasis 13%
41. Gastric Mucosa 13%
42. Oligonucleotide Array Sequence Analysis 13%
43. Magnetic Resonance Imaging 13%
44. Cervix Uteri 12%
45. Helicobacter pylori 12%
46. Oligodendroglioma 12%
47. Pancreatic Neoplasms 12%
48. Progression-Free Survival 11%
49. Indocyanine Green 11%
50. Biopsy 11%